中文 | English
Return
Total: 4036 , 1/404
Show Home Prev Next End page: GO
Author:(Xin-xin ZHOU)

1.How to Protect the Vulnerable Groups in Drug Clinical Trials

Xin LIN ; Xin ZHOU

Chinese Medical Ethics 2017;30(5):572-575

2.Study on in vitro models of drug absorption

Xin ZHOU

Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-

4.Expression and clinical significance of p73? in breast carcinoma tissues

Xin ZHOU

Journal of Chongqing Medical University 1986;0(04):-

5.Research on etiology and drug resistance analysis of ICU ventilator-associated pneumonia

Xin ZHOU

China Medical Equipment 2016;13(1):111-113

6.Exploration on the teaching reform of computer science in medical school

Xin XIONG ; Lihua ZHOU

Chinese Journal of Medical Education Research 2013;(8):806-808

7.Changes and clinical significance of plasma vascular endothelial growth factor of patients with primary liver cancer before and after interventional treatment

Tao ZHOU ; Xin WANG

Clinical Medicine of China 2015;(3):246-248

8.The clinical implications of elevated high-sensitive cardiac troponin

Zhenlu ZHANG ; Xin ZHOU

Chinese Journal of Laboratory Medicine 2014;37(7):555-558

9.Responsibility of mismatch negativity in infant and adult guinea pigs

Xin ZHOU ; Yong LIANG ;

Chinese Archives of Otolaryngology-Head and Neck Surgery 2006;0(12):-

10.Validity of asthma control test questionnaire at primary-care settings in China

Fengming DING ; Xin ZHOU

Chinese Journal of General Practitioners 2009;8(9):628-630

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4036 , 1/404 Show Home Prev Next End page: GO